Breakthrough in Alternative Treatment of Hepatitis B

A recent research shows that Combination Herbal Therapy – “HBV Compound-1 & HBV Compound-2” is very effective in Hepatitis B without any side effects. This Herbal Therapy is a ray of hope for those patients who are not responding to Lamivudine and Baraclude therapy.

  • HBV Compounds Enhances immunity and help to deactivate the viral replication in patients of Hepatitis B.
  • HBV Compounds Quickly normalizes liver enzymes (ALT/SGPT, AST/SGOT) levels in patients of Hepatitis B.
  • HBV Compounds Regenerate damaged liver cells and protect the liver from Cirrhosis in patients of Hepatitis B.

Hepatitis B is the most common serious liver infection in the world, which is caused by infection with the hepatitis B virus (HBV). About 350 million people are chronic carriers of HBV, of whom, more than 250,000 die from liver-related disease each year.

Hepatitis B usually spreads through exposure to infected blood or body secretions. In infected individuals, the virus can be found in the blood, semen, vaginal discharge, breast milk, and saliva. Common means of transmission are:

  • Using contaminated needles for injecting illicit drugs
  • Tattooing
  • Body piercing or Acupuncture

Additionally, Hepatitis B can be transmitted through infected mothers to their babies at birth and through transfused blood products, donated livers and other organs. Hepatitis B can be transmitted through sharing toothbrushes and razors contaminated with infected fluids or blood. Hepatitis B cannot be transmitted hugging or shaking hands with someone who is infected.

Abnormalities in the liver tests (blood tests) also can raise suspicion; however, abnormal liver tests can result from many conditions that affect the liver. The diagnosis of hepatitis B can be made only with specific hepatitis B virus blood tests. Hepatitis B virus has three antigens for which there are commonly-used tests - the surface antigen (HBsAg), the core antigen (HBcAg) and the e antigen (HBeAg).

Hepatitis B virus consists of a core particle (central portion) and a surrounding envelope (outer coat). The core is made up of DNA and the core antigen (HBcAg). The envelope contains the surface antigen (HBsAg). Hepatitis B e antigen (HBeAg) is present when the hepatitis B virus is actively multiplying; another test is 'viral load,' that is, the amount of HBV DNA in the blood.

Hepatitis B can be prevented if person will avoid sharing needles and will have protected sex (use a condom). A vaccine is available to prevent hepatitis B. It is now routinely given in the first year of life to all newborn infants. It is safe and requires 3 shots over a 6-month period. This vaccine should be given to people who are at high risk for this illness, such as health care workers, all children, people who travel to areas where the infection is widespread, drug users and those who have multiple sex partners.

Hepatitis B infection has 2 phases: acute and chronic.

  • Acute (new, short-term) hepatitis B occurs shortly after exposure to the virus. A small number of people develop a very severe, life-threatening form of acute hepatitis called fulminant hepatitis.
  • Chronic (ongoing, long-term) hepatitis B is an infection with HBV that lasts longer than 6 months.
  • Chronic carriers are at increased risk of developing cirrhosis of the liver and hepatocellular carcinoma (HCC), a serious liver cancer.

Hepatitis B Symptoms

Half of all people infected with the hepatitis B virus have no symptoms. Symptoms develop within 30-180 days of exposure to the virus. The symptoms are often compared to flu. Most people think they have flu and never think about having HBV infection.

Loss of Appetite Feeling tired (fatigue)
Nausea and vomiting Itching all over the body
Pain over the liver (on the right side of the abdomen, under the lower rib cage) Jaundice - A condition in which the skin and the whites of the eyes turn yellow in color

Common Blood Tests for Hepatitis B

  • Hepatitis B surface antibody (anti-HBs): a positive result indicates immunity to hepatitis B from the vaccination or recovery from an infection.
  • Hepatitis B surface antigen (HBsAg): A negative result indicates that a person has never been exposed to the virus or has recovered from acute hepatitis and has rid themselves of the virus (or has, at most, an occult infection). A positive (or reactive) result indicates an active infection but does not indicate whether the virus can be passed to others.
  • Hepatitis B e-antigen (HBeAg): A positive (or reactive) result indicates the presence of virus that can be passed to others. A negative result usually means the virus cannot be spread to others, except in parts of the world where infection with strains that cannot make this protein are common.
  • Anti-hepatitis B core antigen (anti-HBc): If it is present with a positive anti-HBs, it usually indicates recovery from an infection and the person is not a carrier or chronically infected. In acute infection, the first type of antibody to HBc to appear is an IgM antibody. Testing for this type of antibody can prove whether a person has recently been infected by HBV (where anti-HBc, IgM would be positive) or for some time (where anti-HBc, IgM would be negative).
  • HBV DNA: A positive (or reactive) result indicates the presence of virus that can be passed to others. A negative result usually means the virus cannot be spread to others, especially if tests that can pick up as few as 200 viruses (copies) in one mL of blood are used.
  • Other liver function tests such as AST, ALT, and gamma-glutamyl transferase (GGT) may be used to monitor the progress of the disease. In some cases, a liver biopsy may be performed for confirmation.